nandrolone has been researched along with Breast Cancer in 80 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 57 (71.25) | 18.7374 |
1990's | 13 (16.25) | 18.2507 |
2000's | 3 (3.75) | 29.6817 |
2010's | 7 (8.75) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chamness, GC; Salman, M | 1 |
Cai, G; Gu, M; Li, X; Mueck, AO; Ruan, X; Wang, L; Zhao, Y | 1 |
Andò, S; Barone, I; Bonofiglio, D; Casaburi, I; Catalano, S; Chimento, A; Giordano, C; Lanzino, M; Maris, P; Morelli, C; Rizza, P; Sirianni, R; Sisci, D | 1 |
Andò, S; Barone, I; Catalano, S; Dahlman Wright, K; De Amicis, F; Giordano, F; Gustafsson, JA; Lanzino, M; Mauro, L; Rizza, P; Sisci, D; Zito, D | 1 |
Abderrahman, B; Curpan, RF; Fan, P; Jordan, VC; Maximov, PY | 1 |
Andò, S; Aquila, S; Avena, P; Casaburi, I; Cesario, MG; Donà, A; Lanzino, M; Morelli, C; Pellegrino, M; Rizza, P; Sisci, D; Tucci, P; Vivacqua, A | 1 |
Bianco-Miotto, T; Birrell, SN; Butler, LM; Clarke, CL; Cops, EJ; Moore, NL; Tilley, WD | 1 |
Andò, S; Capparelli, C; Catalano, S; Chimento, A; Lanzino, M; Panza, S; Pezzi, V; Sirianni, R | 1 |
Cahill, MA; Fehm, T; Mueck, AO; Neubauer, H; Ruan, X; Schneck, H; Seeger, H | 1 |
VAN DER WERFF, JT | 1 |
BROWNE, PA; RIORDAN, DJ | 1 |
SZUJEWSKI, HA | 1 |
DREYFUS, P | 1 |
EMERSON, K; LOUTFI, G; MULLER, J | 1 |
LANGNICKEL, D | 1 |
HIISI-BRUMMER, L; HORTLING, H; MALMIO, K | 2 |
ROTH, CH | 1 |
NISSEN-MEYER, R | 2 |
CUNINGHAM, M; MEYER, KK; SEGALOFF, A; WEETH, JB | 1 |
WILLIAMS, KL | 1 |
HORTLING, H | 1 |
BISEL, HF; CARABASI, RA; VOLK, H; WILDE, RC | 1 |
HISI-BRUMMER, L; HORTLING, H; MALMIO, K | 1 |
Arterburn, JB; Dai, D; Hathaway, HJ; Nayak, TK; Norenberg, JP; Prossnitz, ER; Ramesh, C; Sklar, LA | 1 |
Hortling, H; Malmio, K | 1 |
Stoll, BA | 1 |
Bodek, B; Görlich, M; Heise, E; Kunde, D; Marx, G; Nissen, E; Peek, U; Projan, A; Tanneberger, S; Winkler, R | 1 |
Nash, AR; Ow, KT; Sarfaty, GA | 1 |
Bentel, JM; Birrell, SN; Hickey, TE; Horsfall, DJ; Ricciardelli, C; Tilley, WD; Weger, MA | 1 |
Netsuwan, N; Traish, AM | 1 |
Birrell, SN; Hall, RE; Sutherland, RL; Tilley, WD | 1 |
Blaschke, D; Hermeking, H; Herzinger, T; Hörz, W; Wolf, DA | 1 |
Joosten, JW; Kloosterboer, HJ; Schoonen, WG | 2 |
Aoki, D; Katsuki, Y; Nozawa, S; Shibutani, Y | 1 |
Jimenez, J; Luizzi, MF; Sonnenschein, C; Soto, AM; Szelei, J | 1 |
de Bruin, K; Janssen, AG; Rijks, LJ; van den Bos, JC; van Doremalen, PA; van Royen, EA | 1 |
Boer, GJ; de Bruin, K; Janssen, AG; Rijks, LJ; van den Bos, JC; van Doremalen, PA; van Royen, EA | 1 |
Diamandis, EP; Jenkins, DJ; Rosenberg Zand, RS | 1 |
Skouby, SO | 1 |
Rieche, K; Wolff, G | 1 |
Algeri, R; Camarri, E; Giomi, S | 1 |
Edelstyn, GA; MacRae, KD | 1 |
Banks, AJ; Bond, WH; Chowdhury, MS; Jones, WG; Ward, HW | 1 |
Dickey, RP; Stone, SC | 1 |
Hadziev, S; Kavaklieva-Dimtrova, J; Mandulova, P | 1 |
Bennett, MB; Helman, P; Palmer, P | 1 |
Bradbeer, JW; Pain, JA; Wickremesinghe, SS | 1 |
Chamness, GC; Salman, M; Stotter, PL | 1 |
Li, GC; Liu, GS | 1 |
Brandes, SJ; Katzenellenbogen, JA | 1 |
Ginsburg, KA; Moghissi, KS | 1 |
Blackstein, M; Daniilescu, D; Kharlip, L; Killinger, DW; Perel, E | 1 |
Chamness, GC; Ruiz, AA; Salman, M; Stotter, PL | 1 |
Huovinen, R; Johansson, R; Kellokumpu-Lehtinen, P | 1 |
Alanko, A; Gröhn, P; Heinonen, E; Rissanen, P | 1 |
Alanko, A; Heinonen, E; Scheinin, T; Tolppanen, EM; Vihko, R | 1 |
Greening, WP; Lawler, SD; McKinna, JA; Pentycross, CR; Toussis, D | 1 |
Arthur, K | 1 |
Atkins, H; Bulbrook, RD; Falconer, MA; Hayward, JL; MacLean, KS; Schurr, PH | 1 |
Dao, TL; Libby, PR | 1 |
Cleton, FJ; Engelsman, E; Korsten, CB; Persijn, JP | 2 |
Hähnel, R; Twaddle, E | 1 |
Besa, EC; Gardner, FH; Gorshein, D | 1 |
Brodsky, I; Conroy, JF; Kahn, SB | 1 |
Cole, MP; Todd, ID; Wilkinson, PM | 1 |
Bisel, HF; Goldenberg, IS; Haines, CR; Olson, KB; Talley, RW; Waters, MN | 1 |
Brodsky, I | 1 |
Prahl, B; Wolff, G | 1 |
Derriks, R; Heynen, E; Mannes, P; Moens, R | 1 |
Bennett, MB; Helman, P | 1 |
Macmichael, IM | 1 |
Kleibel, F | 1 |
Demol, R | 1 |
Doorenbos, H | 1 |
Dupas, M; Redon, H | 1 |
5 review(s) available for nandrolone and Breast Cancer
Article | Year |
---|---|
The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy.
Topics: Apoptosis; Breast Neoplasms; Drug Resistance, Neoplasm; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Mutation; Nandrolone; Receptors, Estrogen | 2015 |
The rationale for a wider range of progestogens.
Topics: Androstenes; Biological Availability; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Endometrial Neoplasms; Estranes; Estrogen Replacement Therapy; Female; Gonanes; Humans; Nandrolone; Osteoporosis, Postmenopausal; Pregnanes; Primary Prevention; Progestins; Treatment Outcome | 2000 |
Drugs that affect the breast and lactation.
Topics: Androgens; Apomorphine; Barbiturates; Breast; Breast Neoplasms; Bromocriptine; Contraceptives, Oral, Hormonal; Estrogens; Female; Galactorrhea; Humans; Lactation; Levodopa; Male; Monoamine Oxidase Inhibitors; Nandrolone; Phenothiazines; Pregnancy; Progesterone; Prolactin; Psychotropic Drugs; Pyridoxine; Steroids | 1975 |
Fundamental considerations in the design of fluorine-18 labeled progestins and androgens as imaging agents for receptor-positive tumors of the breast and prostate.
Topics: Androgens; Breast Neoplasms; Female; Fluorine Radioisotopes; Humans; Male; Nandrolone; Neoplasms, Hormone-Dependent; Progesterone; Progesterone Congeners; Prostatic Neoplasms; Protein Binding; Radionuclide Imaging; Receptors, Androgen; Receptors, Estrogen; Sex Hormone-Binding Globulin; Structure-Activity Relationship; Testosterone; Transcortin | 1988 |
Alternate delivery systems for contraceptive progestogens.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Breast Neoplasms; Contraceptive Agents; Contraceptive Devices; Female; Humans; Injections; Injections, Subcutaneous; Intrauterine Devices, Medicated; Liver Neoplasms; Menstruation Disturbances; Nandrolone; Ovary; Pregnanes; Progestins | 1988 |
11 trial(s) available for nandrolone and Breast Cancer
Article | Year |
---|---|
[Androgen therapy of incurable breast neoplasms. Controlled clinical study: nandrolone-testololactone-drostanolone].
Topics: Androstanols; Androstenes; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Female; Humans; Nandrolone; Testolactone; Testosterone Congeners; Virilism | 1978 |
A comparison of drostanolone propionate (Masteril) and nandrolone decanoate (Deca-durabolin) in the treatment of breast carcinoma.
Topics: Androstanols; Breast Neoplasms; Humans; Nandrolone; Virilism | 1976 |
Hormonal therapy of breast cancer with special reference to Masteril therapy.
Topics: Adult; Aged; Androgens; Androstanols; Breast Neoplasms; Castration; Ethinyl Estradiol; Female; Humans; Menopause; Middle Aged; Nandrolone | 1975 |
Combined tamoxifen and anabolic steroid as primary treatment for breast carcinoma in the elderly.
Topics: Aged; Anabolic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Nandrolone; Nandrolone Decanoate; Prospective Studies; Remission Induction; Tamoxifen | 1990 |
Hormonal treatment of advanced breast cancer. A randomized trial of tamoxifen versus nandrolone decanoate.
Topics: Breast Neoplasms; Drug Evaluation; Female; Humans; Nandrolone; Nandrolone Decanoate; Random Allocation; Tamoxifen | 1987 |
Nandrolone decanoate added to tamoxifen in the treatment of advanced breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Middle Aged; Nandrolone; Nandrolone Decanoate; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1985 |
Effect of hormone therapy on mitogenic responses of lymphocytes from patients with cancer of the breast.
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Diethylstilbestrol; Female; Humans; Lectins; Lymphocyte Activation; Lymphocytes; Menopause; Middle Aged; Mitosis; Mononuclear Phagocyte System; Nandrolone; Postoperative Care; Preoperative Care; Prospective Studies; T-Lymphocytes | 1973 |
Ten years' experience of sterioid assays in the management of breast cancer. A review.
Topics: 17-Hydroxycorticosteroids; Adrenalectomy; Breast Neoplasms; Diethylstilbestrol; Ethinyl Estradiol; Female; Humans; Hypophysectomy; Mastectomy; Menopause; Nandrolone; Neoplasm Metastasis; Pituitary Irradiation; Prognosis | 1968 |
Cyclophosphamide and nandrolone decanoate in the treatment of advanced carcinoma of the breast--results of a comparative controlled trial of the agents used singly and in combination.
Topics: Administration, Oral; Adult; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Combinations; Female; Hair; Hair Removal; Humans; Injections, Intravenous; Leukocytes; Middle Aged; Nandrolone; Vomiting | 1973 |
A dose-response evaluation of androgens in the treatment of metastatic breast cancer.
Topics: Androstanols; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Humans; Nandrolone; Neoplasm Metastasis; Remission, Spontaneous; Time Factors | 1973 |
[A controlled clinical trial for hormonal and combined cyclophosphamide-hormonal treatment of incurable breast cancer (author's transl)].
Topics: Androgens; Breast Neoplasms; Castration; Cyclophosphamide; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Nandrolone; Neoplasm Metastasis; Norethindrone; Propionates; Time Factors | 1973 |
64 other study(ies) available for nandrolone and Breast Cancer
Article | Year |
---|---|
A potential radioiodinated ligand for androgen receptor: 7 alpha-methyl-17 alpha-(2'-(E)-iodovinyl)-19-nortestosterone.
Topics: Animals; Binding, Competitive; Breast Neoplasms; Chemical Phenomena; Chemistry; Dihydrotestosterone; Female; Humans; Iodine Radioisotopes; Molecular Structure; Nandrolone; Rats; Rats, Inbred Strains; Receptors, Androgen; Tumor Cells, Cultured; Uterus | 1991 |
Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study.
Topics: Androstenes; Animals; Breast Neoplasms; Cell Proliferation; Cyproterone Acetate; Dydrogesterone; Estradiol; Female; Heterografts; Humans; In Vitro Techniques; MCF-7 Cells; Megestrol; Membrane Proteins; Mice; Mice, Nude; Nandrolone; Norethindrone; Progesterone; Progestins; Prospective Studies; Receptors, Progesterone | 2019 |
DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation.
Topics: Androgens; Apoptosis; Aromatase; Base Sequence; Breast Neoplasms; Cell Proliferation; DAX-1 Orphan Nuclear Receptor; Enzyme Repression; Estrogens; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Nandrolone; Neoplasms, Hormone-Dependent; Promoter Regions, Genetic; Receptors, Androgen; Response Elements | 2013 |
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Enzyme Activation; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; MCF-7 Cells; Mutagenesis, Site-Directed; Nandrolone; Promoter Regions, Genetic; Protein Binding; Receptors, Androgen; rho GTP-Binding Proteins; RNA Interference; RNA Polymerase II; RNA, Messenger; RNA, Small Interfering; Testosterone Congeners; Up-Regulation | 2014 |
Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor.
Topics: Androgens; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Nandrolone; Receptors, Androgen | 2016 |
Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors.
Topics: Androgens; Breast Neoplasms; Cell Proliferation; Dihydrotestosterone; Drug Evaluation, Preclinical; Estradiol; Humans; Medroxyprogesterone Acetate; Nandrolone; Progestins; Receptors, Androgen; Receptors, Progesterone; Testosterone Congeners; Tumor Cells, Cultured | 2008 |
Nandrolone and stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation.
Topics: Anabolic Agents; Androgens; Aromatase; Breast Neoplasms; Cell Proliferation; Cell Survival; Drug Synergism; Enzyme Induction; Estradiol; Estrogen Receptor alpha; Female; Genes, Reporter; Humans; Insulin-Like Growth Factor I; Luciferases, Renilla; MCF-7 Cells; Nandrolone; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Stanozolol; Type C Phospholipases; Up-Regulation | 2012 |
Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells.
Topics: Breast Neoplasms; Cell Proliferation; Clone Cells; Contraceptive Agents, Female; Drug Interactions; Estradiol; Estrogens; Female; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Membrane Proteins; Nandrolone; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Norethindrone; Osmolar Concentration; Progesterone; Progestins; Receptors, Progesterone; Recombinant Proteins | 2013 |
Sex hormones and mammary cancer; experience with durabolin.
Topics: Breast; Breast Neoplasms; Gonadal Steroid Hormones; Humans; Nandrolone; Testosterone | 1958 |
The treatment of secondary deposits in bone from carcinoma of the breast with radio-active phosphorus and Durabolin.
Topics: Bone and Bones; Bone Neoplasms; Breast; Breast Neoplasms; Humans; Nandrolone; Neoplasms; Phosphorus; Phosphorus Radioisotopes; Testosterone | 1961 |
Nandrolone phenpropionate: a new palliative agent in the management of mammary carcinoma.
Topics: Breast; Breast Neoplasms; Disease Management; Humans; Nandrolone; Testosterone | 1959 |
[Durabolin in bone pathology].
Topics: Breast; Breast Neoplasms; Humans; Nandrolone; Osteoporosis; Testosterone | 1961 |
Paradoxical response of metastatic breast cancer to 17-ethyl-19-nortestosterone.
Topics: Breast; Breast Neoplasms; Humans; Nandrolone; Testosterone | 1961 |
[On the treatment of malignant tumors with tris-ethyleneimonobenzoquinone, 19-norandrostenolone decanoate and prednisone].
Topics: Antineoplastic Agents; Breast Neoplasms; Decanoates; Female; Humans; Nandrolone; Nandrolone Decanoate; Neoplasms; Ovarian Neoplasms; Prednisolone; Prednisone; Stomach Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms | 1963 |
Endocrine treatment of metastasizing breast cancer.
Topics: Anatomy; Breast Neoplasms; Castration; Estrogens; Humans; Hypophysectomy; Nandrolone; Neoplasm Metastasis; Neoplasms | 1962 |
ANABOLIC STEROIDS: REVIEW WITH EMPHASIS ON USE IN OSTEOPOROSIS, SELECTED MALIGNANCIES, AND IN CORTICOSTEROID AND ACTH THERAPY.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anabolic Agents; Breast Neoplasms; Female; Genital Neoplasms, Female; Geriatrics; Humans; Liver Neoplasms; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Nandrolone; Neoplasms; Norethandrolone; Osteoporosis; Sarcoma; Steroids; Stomach Neoplasms; Tongue Neoplasms | 1963 |
PROPHYLACTIC ENDOCRINE TREATMENT IN CARCINOMA OF THE BREAST.
Topics: Androgens; Breast Neoplasms; Castration; Cortisone; Estrogens; Female; Humans; Mastectomy; Menopause; Nandrolone; Neoplasm Metastasis; Neoplasms; Ovary; Palliative Care; Prednisone; Progesterone; Testosterone | 1964 |
ENDOCRINE TREATMENT OF BREAST CANCER.
Topics: Anabolic Agents; Androgens; Breast Neoplasms; Castration; Estrone; Female; Humans; Menopause; Nandrolone; Neoplasm Metastasis; Neoplasms; Ovary; Prednisone; Steroids; Testosterone; Urine | 1964 |
HORMONAL THERAPY IN CANCER OF THE BREAST. 23. EFFECT OF 7-ALPHA-METHYL-19-NORTESTOSTERONE ACETATE AND TESTOSTERONE PROPIONATE ON CLINICAL COURSE AND HORMONAL EXCRETION.
Topics: 17-Ketosteroids; Acetates; Antineoplastic Agents; Bilirubin; Biomedical Research; Blood Glucose; Breast Neoplasms; Female; Fluids and Secretions; Gonadotropins; Gonadotropins, Pituitary; Humans; Kidney Function Tests; Nandrolone; Neoplasms; Nitrogen; Prolactin; Testosterone; Testosterone Propionate; Toxicology; Transaminases; Urea; Urine; Virilism | 1964 |
TEMPERATURE MEASUREMENT IN BREAST DISEASE.
Topics: Body Temperature; Breast Diseases; Breast Neoplasms; Diethylstilbestrol; Humans; Infrared Rays; Nandrolone; Neoplasms; Skin; Temperature; Thermography | 1964 |
THE ENDOCRINE TREATMENT OF METASTATIC BREAST CANCER.
Topics: Adrenalectomy; Anabolic Agents; Androgens; Breast Neoplasms; Castration; Cortisone; Drug Therapy; Estrogens; Female; Geriatrics; Humans; Hypophysectomy; Male; Nandrolone; Neoplasm Metastasis; Neoplasms; Orchiectomy; Ovary; Steroids; Testosterone | 1965 |
ANTITUMOR EFFICACY OF NORANDROLONE PHENPROPIONATE COMPARED WITH TESTOSTERONE PROPIONATE IN ADVANCED BREAST CANCER.
Topics: Breast; Breast Neoplasms; Drug Therapy; Geriatrics; Humans; Nandrolone; Neoplasms; Testosterone; Testosterone Propionate | 1965 |
The clinical effect of norandrostenolone phenylpropionate (durabolin) in metastasizing mammary cancer patients.
Topics: Breast; Breast Neoplasms; Humans; Nandrolone; Neoplasms; Phenylpropionates; Testosterone | 1960 |
Norandrostenolone phenylpropionate and norandrostenolone decanoate in the treatment of metastasizing mammary carcinoma.
Topics: Breast; Breast Neoplasms; Decanoates; Humans; Nandrolone; Nandrolone Decanoate; Neoplasms; Phenylpropionates | 1961 |
Preclinical development of a neutral, estrogen receptor-targeted, tridentate 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Dihydrotestosterone; Drug Delivery Systems; Drug Evaluation, Preclinical; Endometrial Neoplasms; Female; Humans; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Nandrolone; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Estrogen; Tissue Distribution | 2008 |
[Treatment of metastasizing breast cancer with anabolic steroids].
Topics: Adrenalectomy; Anabolic Agents; Breast Neoplasms; Castration; Estrogens; Female; Humans; Hypophysectomy; Nandrolone; Neoplasm Metastasis; Prognosis; Testosterone | 1967 |
Progestin therapy of breast cancer: comparison of agents.
Topics: Aged; Breast Neoplasms; Evaluation Studies as Topic; Female; Humans; Hydroxyprogesterones; Middle Aged; Nandrolone; Progestins; Testosterone; Vaginal Smears | 1967 |
High risk breast cancer: long-term surgical adjuvant therapy based on predictive tests - preliminary report.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Castration; Drug Resistance; Drug Therapy, Combination; Female; Humans; Mastectomy; Middle Aged; Nandrolone; Prognosis; Receptors, Estrogen | 1981 |
The effects of steroids on phytohaemagglutin-induced lymphoblastogenesis.
Topics: Adult; Breast Neoplasms; Dihydrotestosterone; DNA Replication; Estradiol; Female; Fibrocystic Breast Disease; Hormones; Humans; Lymphocyte Activation; Lymphocytes; Male; Menstruation; Nandrolone; Phytohemagglutinins; Steroids | 1980 |
Androgens induce divergent proliferative responses in human breast cancer cell lines.
Topics: Androgen Receptor Antagonists; Androgens; Breast Neoplasms; Cell Division; Dihydrotestosterone; Flutamide; Humans; Imidazoles; Imidazolidines; Nandrolone; Oligonucleotides, Antisense; Receptors, Androgen; Tumor Cells, Cultured | 1995 |
7 alpha-17 alpha-Dimethyl-19-nortestosterone (mibolerone) induces conformational changes in progesterone receptors distinct from those induced by ORG 2058.
Topics: Animals; Binding Sites, Antibody; Binding, Competitive; Blotting, Western; Breast Neoplasms; Cattle; Female; Humans; Nandrolone; Precipitin Tests; Pregnenediones; Protein Conformation; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Progesterone; Uterus | 1994 |
MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression.
Topics: Blotting, Southern; Breast Neoplasms; Cell Division; Dihydrotestosterone; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Middle Aged; Nandrolone; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Testosterone Congeners; Tumor Cells, Cultured | 1994 |
Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen.
Topics: Androgens; Antibodies; Base Sequence; Blotting, Northern; Breast Neoplasms; Cells, Cultured; Down-Regulation; Fibroblasts; Gene Expression Regulation; Humans; Immunohistochemistry; Male; Molecular Sequence Data; Nandrolone; Prostatic Neoplasms; Protein Processing, Post-Translational; Receptors, Androgen; RNA, Messenger; Time Factors; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 1993 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Desogestrel; Estradiol; Estrogen Antagonists; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Models, Statistical; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured | 1995 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured | 1995 |
Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Screening Assays, Antitumor; Endometrial Neoplasms; Female; Hormone Antagonists; Humans; Mice; Mice, SCID; Nandrolone; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured | 1997 |
Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor.
Topics: Androgen Antagonists; Androgens; Anilides; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Division; Dihydrotestosterone; Dose-Response Relationship, Drug; Female; Flutamide; Humans; In Vitro Techniques; Metribolone; Nandrolone; Nitriles; Receptors, Androgen; Testosterone; Testosterone Congeners; Tosyl Compounds; Transfection; Tumor Cells, Cultured | 1997 |
New iodinated progestins as potential ligands for progesterone receptor imaging in breast cancer. Part 1: Synthesis and in vitro pharmacological characterization.
Topics: Animals; Breast Neoplasms; Chromatography, Gel; Female; Humans; Iodine Radioisotopes; Ligands; Magnetic Resonance Spectroscopy; Nandrolone; Progesterone Congeners; Radiopharmaceuticals; Rats; Receptors, Progesterone; Tomography, Emission-Computed, Single-Photon; Tumor Cells, Cultured | 1998 |
New iodinated progestins as potential ligands for progesterone receptor imaging in breast cancer. Part 2: In vivo pharmacological characterization.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Female; Humans; Iodine Radioisotopes; Ligands; Mammary Neoplasms, Experimental; Nandrolone; Ovary; Progesterone Congeners; Rabbits; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Uterus | 1998 |
Development and evaluation of a competitive time-resolved immunofluorometric assay for the estrogen-regulated protein pS2.
Topics: Aldosterone; Amino Acid Sequence; Antibodies, Monoclonal; Binding, Competitive; Biotin; Breast Neoplasms; Calibration; Chemistry, Clinical; Dexamethasone; Dihydrotestosterone; Dose-Response Relationship, Immunologic; Drosophila Proteins; Estradiol; Evaluation Studies as Topic; Fluorescent Antibody Technique; Fluorometry; Glucocorticoids; Integrin alpha Chains; Integrins; Molecular Sequence Data; Nandrolone; Norgestrel; Progesterone Congeners; Sensitivity and Specificity; Testosterone Congeners; Tumor Cells, Cultured | 1999 |
[High doses of anabolic steroids in collateral therapy of malignant neoplasms. Results with 19-norandrostenolone undecylate].
Topics: Adenocarcinoma; Aged; Anabolic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Female; Gastrointestinal Neoplasms; Humans; Leukemia, Lymphoid; Male; Middle Aged; Nandrolone; Nasopharyngeal Neoplasms; Neoplasms | 1978 |
Concomitant androgen therapy in the management of advanced breast cancer by cyclical combined chemotherapy.
Topics: Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Hemoglobins; Humans; Methotrexate; Nandrolone; Neoplasm Metastasis; Oxymetholone; Vincristine | 1976 |
Therapeutic effect of a water-salt extract from BCG in two patients with advanced breast cancer.
Topics: Adenocarcinoma; Adult; Aged; BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Decanoates; Female; Humans; Immunotherapy; Lung Neoplasms; Lymphatic Metastasis; Mycobacterium bovis; Nandrolone; Neoplasm Metastasis; Testosterone | 1975 |
125I-ligand for progesterone receptor: 17 alpha-(6'-iodohex-1'-ynyl)-19-nortestosterone.
Topics: Binding, Competitive; Breast Neoplasms; Cytosol; Female; Humans; Indicators and Reagents; Iodine Radioisotopes; Kinetics; Ligands; Mass Spectrometry; Nandrolone; Receptors, Progesterone; Tumor Cells, Cultured | 1989 |
Further study of five-drug combined chemotherapy for advanced breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Nandrolone; Prednisone; Thiotepa; Vincristine | 1986 |
Steroid modulation of aromatase activity in human cultured breast carcinoma cells.
Topics: Androstenedione; Aromatase; Breast Neoplasms; Carcinoma; Cell Division; Estradiol; Estrone; Humans; Hydrocortisone; Nandrolone; Tumor Cells, Cultured | 1988 |
A progesterone receptor affinity chromatography reagent: 17 alpha-hexynyl nortestosterone sepharose.
Topics: Animals; Breast Neoplasms; Cell Line; Chemical Phenomena; Chemistry; Chromatography, Affinity; Electrophoresis, Polyacrylamide Gel; Female; Humans; Nandrolone; Promegestone; Rats; Rats, Inbred Strains; Receptors, Progesterone; Sepharose; Uterus | 1987 |
Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients.
Topics: Breast Neoplasms; Female; Humans; Mastectomy; Nandrolone; Nandrolone Decanoate; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Time Factors | 1985 |
Some aspects of chemotherapy in breast carcinomatosis.
Topics: Adrenalectomy; Bone Marrow Diseases; Breast Neoplasms; Carcinoma; Cyclophosphamide; Female; Humans; Hypophysectomy; Menopause; Methyltestosterone; Nandrolone; Neoplasm Metastasis; Palliative Care; Thiotepa | 1968 |
Conjugation of steroid hormones by normal and neoplastic tissues.
Topics: Adult; Aged; Breast; Breast Neoplasms; Chromatography, Paper; Dehydroepiandrosterone; Desoxycorticosterone; Estradiol; Female; Humans; Hydrogen-Ion Concentration; Liver; Liver Neoplasms; Middle Aged; Nandrolone; Neoplasm Metastasis; Pregnenolone; Steroids; Sulfates; Sulfur Isotopes; Transferases | 1968 |
Hormones in advanced cancer.
Topics: Acne Vulgaris; Adrenal Cortex Hormones; Adrenalectomy; Androgens; Androstanols; Breast Neoplasms; Estrogens; Female; Hirsutism; Hormones; Humans; Hypercalcemia; Hypertension; Hypophysectomy; Male; Nandrolone; Norethindrone; Ovarian Neoplasms; Progesterone; Prostatic Neoplasms; Thyroid Hormones; Thyroid Neoplasms; Urogenital Neoplasms; Uterine Neoplasms; Vasopressins | 1971 |
Oestrogen receptor in human breast cancer tissue and response to endocrine therapy.
Topics: Breast Neoplasms; Castration; Estrogens; Ethinyl Estradiol; Female; Hormones; Humans; Hypercalcemia; Nandrolone; Naphthalenes; Phenols; Pyrrolidines; Receptors, Cell Surface | 1973 |
The steroid specificity of the estrogen-receptor of human breast carcinoma.
Topics: Androstanes; Androstenols; Binding Sites; Breast; Breast Neoplasms; Carcinoma; Cytosol; Dehydroepiandrosterone; Estradiol; Estriol; Estrone; Female; Glycosides; Humans; Hydroxysteroids; Mastectomy; Nandrolone; Progesterone; Receptors, Cell Surface; Structure-Activity Relationship; Tritium | 1974 |
Androgens and human blood volume changes. Comparison in normal and various anemic states.
Topics: Adolescent; Adult; Aged; Anemia, Sickle Cell; Anemia, Sideroblastic; Blood Volume; Breast Neoplasms; Erectile Dysfunction; Erythrocyte Count; Female; Hematocrit; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Nandrolone; Plasma Volume; Stomach Neoplasms; Time Factors | 1974 |
Effect of nandrolone phenpropionate on myelopoiesis.
Topics: Agranulocytosis; Anabolic Agents; Bone Marrow; Bone Marrow Cells; Bone Marrow Diseases; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Injections, Intramuscular; Leukemia, Lymphoid; Leukocyte Count; Male; Multiple Myeloma; Nandrolone; Neutropenia; Phenylpropionates | 1974 |
The role of androgens and anabolic steroids in the treatment of cancer.
Topics: Adenocarcinoma; Agranulocytosis; Anabolic Agents; Androgens; Antineoplastic Agents; Bone Marrow Diseases; Breast Neoplasms; Carcinoma, Squamous Cell; Female; Fibrinolysis; Humans; Immunity; Intestinal Neoplasms; Leukocyte Count; Liposarcoma; Lymphoma, Non-Hodgkin; Male; Multiple Myeloma; Nandrolone; Testosterone; Uterine Cervical Neoplasms | 1973 |
Human breast cancer and estrogen receptor.
Topics: Adrenalectomy; Breast Neoplasms; Castration; Estrogens; Ethinyl Estradiol; Female; Humans; Hypophysectomy; Male; Nafoxidine; Nandrolone | 1973 |
[Antineoplastic polychemotherapy in thoracic pathology].
Topics: Adrenalectomy; Aged; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Cortisone; Cyclophosphamide; Drug Synergism; Ethinyl Estradiol; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Hydrazines; Hypophysectomy; Kidney Neoplasms; Lung Neoplasms; Male; Melanoma; Melphalan; Mesothelioma; Methotrexate; Middle Aged; Nandrolone; Neoplasm Metastasis; Ovarian Neoplasms; Podophyllin; Sarcoma; Thiotepa; Vinblastine | 1968 |
Hormone therapy of breast cancer with special reference to masteril therapy.
Topics: Androgens; Androstanols; Body Weight; Breast Neoplasms; Castration; Ethinyl Estradiol; Female; Menopause; Nandrolone; Neoplasm Metastasis; Propionates; Virilism | 1972 |
Management of choroidal metastases from breast carcinoma.
Topics: Adult; Breast Neoplasms; Choroid Neoplasms; Diethylstilbestrol; Female; Humans; Middle Aged; Nandrolone; Neoplasm Metastasis; Vision, Ocular | 1969 |
[Long-acting anabolic agent (clinibolin) as an adjuvant in tumor therapy].
Topics: Blood Proteins; Breast Neoplasms; Bronchial Neoplasms; Female; Hodgkin Disease; Humans; Male; Nandrolone; Neoplasms; Ovarian Neoplasms; Pharmaceutic Aids; Testicular Neoplasms; Tonsillar Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 1969 |
[Hormone treatment of breast cancer in the advanced phase].
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Fluoxymesterone; Gonadotropins; Humans; Lactones; Nandrolone; Phenanthrenes; Secosteroids; Testolactone; Testosterone | 1968 |
[Conservative hormonal treatment of metastatic mammary cancer].
Topics: Breast Neoplasms; Estrogens; Female; Humans; Nandrolone; Neoplasm Metastasis; Ovary; Prednisone; Radiation Effects | 1966 |
[Apropos of intra-arterial chemotherapy in the treatment of breast cancers].
Topics: Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Injections, Intra-Arterial; Nandrolone | 1966 |